Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma
Authors
Nakashima, S
Natsugoe, S
Matsumoto, M
Kijima, F
Takebayashi, Y
Okumura, H
Shimada, M
Nakano, S
Kusano, C
Baba, M
Takao, S
Aikou, T
Citation
S. Nakashima et al., Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma, ANTICANC R, 20(3B), 2000, pp. 1933-1937
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
SICI code
0250-7005(200005/06)20:3B<1933:EOPAPI>2.0.ZU;2-8
Abstract
The p53 and p21 genes are associated with GI arrest during the cell cycle a
nd with apoptosis, both of which have a close relationship with the effect
of chemotherapy. In this study, we investigated the correlation between p53
and p21 expression in biopsy specimens and the histological effect of chem
otherapy in esophageal carcinoma. A total of 30 patients with esophageal sq
uamous cell carcinoma received preoperative chemotherapy, then underwent es
ophagectomy with lymph node dissection. The response rate of primary lesion
and metastatic nodes was 20.0% and 25.9%, respectively. The positive rate
of p53 and p21 expression was 56.7% and 36.7%, respectively. Preoperative c
hemotherapy against primary lesions was ineffective in all the patients who
expressed p53, but not p21. In contrast, chemotherapy was effective agains
t metastatic lymph nodes which were p53 negative bur p21 positive. These fi
ndings suggest that p21 positive expression in the absence of p53 is associ
ated with favorable effects of preoperative chemotherapy in patients with e
sophageal carcinoma. Therefore, the expression of these genes should be exa
mined in biopsy specimens to predict the chemotherapeutic outcome in patien
ts with esophageal carcinoma.